NCT00437983

The Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment

A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Phosphatidylserine-Omega3 in Elderly With Age Associated Memory Impairment

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 157 (actual)
• Sponsor: Enzymotec · Industry
• Sex: All
• Age: 50 Years – 90 Years
• Healthy volunteers: Accepted

Summary

The primary objective of this trial is to assess the ability of an oral administration of Phosphatidylserine-Omega3 to improve attention and memory complaints in comparison to placebo in age associated memory impaired subjects.

Conditions

• Age Associated Memory Impairment

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	PS-Omega3	Phosphatidylserine-Omega3 capsules 3x100mg/day 15 wk. Next, follow up phase, open label,1x100mg/day, 15 wk
DIETARY_SUPPLEMENT	Placebo	Placebo cellulose tainted with fishy odor capsules 3x100mg/day 15 wk

Timeline

• Start date: 2007-04-01
• Primary completion: 2008-06-01
• Completion: 2008-09-01
• First posted: 2007-02-21
• Last updated: 2010-01-05
• Results posted: 2009-11-25

Locations

1 site across 1 country: Israel